Bennett Professor of Evidence-Based Medicine
Director of Bennett Institute for Applied Data Science
Ben Goldacre is a doctor, academic, best-selling author, and campaigner. He trained in medicine at Oxford and UCL, in psychiatry at the Maudsley, and in epidemiology at LSHTM. His academic and policy work is in epidemiology and evidence based medicine, where he works on various problems including variation in care, better uses of routinely collected electronic health data, access to clinical trial data, and efficient trial design.
He has also written government papers on evidence based policy, and founded a successful global campaign for research transparency. His book Bad Science reached #1 in the UK non-fiction charts and has sold over half a million copies worldwide. A longer bio is available on his Nuffield Department of Primary Care Health Sciences profile, and he is on Twitter @bengoldacre.
Papers by Ben Goldacre

Impact of Electronic Health Record Interface Design on Unsafe Prescribing of Ciclosporin, Tacrolimus, and Diltiazem: Cohort Study in English National Health Service Primary Care

Suboptimal prescribing behaviour associated with clinical software design features: a retrospective cohort study in English NHS primary care

(PRE-PRINT) OpenSAFELY: Do adults prescribed Non-steroidal anti-inflammatory drugs have an increased risk of death from COVID-19?

Prescription of suboptimal statin treatment regimens: a retrospective cohort study of trends and variation in English primary care

The NHS deserves better use of hospital medicines data

Bringing NHS data analysis into the 21st century

Trends and variation in unsafe prescribing of methotrexate: a cohort study in English NHS primary care.

Better use of data and digital offer rapid opportunities to address covid-19

The poor performance of apps assessing skin cancer risk

Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study

Barriers to Working With National Health Service England's Open Data

Practice variation in the use of tests in UK primary care: a retrospective analysis of 16 million tests performed over 3.3 million patient years in 2015/16

Why researchers should share their analytic code

[PRE-PRINT] FDAAA TrialsTracker: A live informatics tool to monitor compliance with FDA requirements to report clinical trial results

Variation in responsiveness to warranted behaviour change among NHS clinicians: novel implementation of change detection methods in longitudinal prescribing data

Personalised Medicine Using N-of-1 Trials: Overcoming Barriers to Delivery

Impact of Chief Medical Officer activity on prescribing of antibiotics in England: an interrupted time series analysis

Is Use of Homeopathy Associated With Poor Prescribing in English Primary Care? A Cross-Sectional Study

COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time.

COMPare: Qualitative analysis of researchers' responses to critical correspondence on a cohort of 58 misreported trials

Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.

Measuring the Impact of an Open Web-Based Prescribing Data Analysis Service on Clinical Practice: Cohort Study on NHS England Data

Why did some practices not implement new antibiotic prescribing guidelines on urinary tract infection? A cohort study and survey in NHS England primary care

Opioid prescribing trends and geographical variation in England, 1998–2018: a retrospective database study

Six months on – NHS England needs to focus on dissemination, implementation and audit of its Low-Priority Initiative

Temporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million tests

Time trends and geographical variation in prescribing of antibiotics in England 1998–2017

Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource.

Reply to Comment on 'Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis'

Detecting Change in Comparison to Peers in NHS Prescribing Data: a Novel Application of Cumulative Sum Methodology

Pregabalin: what the patent litigation means for doctors and drug companies

The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary care

Trends and variation in prescribing of low-priority treatments identified by NHS England: a cross-sectional study and interactive data tool in English primary care

Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017

Noncommercial Funders' Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability.

Trends, geographical variation and factors associated with prescribing of gluten-free foods in English primary care: a cross-sectional study

A cross-sectional study of all clinicians' conflict of interest disclosures to NHS hospital employers in England 2015-2016.

Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net

Prevalence of clinical trial status discrepancies: A cross-sectional study of 10,492 trials registered on both ClinicalTrials.gov and the European Union Clinical Trials Register.

OpenPrescribing: normalised data and software tool to research trends in English NHS primary care prescribing 1998–2016

New mechanism to identify cost savings in English NHS prescribing: minimising 'price per unit', a cross-sectional study

Pharmaceutical companies' policies on access to trial data, results, and methods: audit study.

The WHO joint statement from funders on trials transparency

The TrialsTracker: Automated ongoing monitoring of failure to share clinical trial results by all major companies and research institutions.

OpenTrials: towards a collaborative open database of all available information on all clinical trials

Fixing flaws in science must be professionalized

Antivirals, pandemic planning, and failure to heed calls for trial data

How to get all trials reported: audit, better data, and individual accountability
Blogs by Ben Goldacre

National Institute for Health and Care Excellence — NICE Prescribing Dashboards
FDAAA TrialsTracker Milestones: 6 Months, >1200 trials, $500 Million in Fines
"PPPI": why academics should engage Patients, the Public *and* Professionals
An unreported clinical trial… from the FDA themselves
Welcoming our new Bennett Institute team member, Darren Smyth: a lawyer!
Our FDAAA TrialsTracker is already helping to get new trials reported!
